OVID THERAPEUTICS INC. - COMMON STOCK

Ovid Therapeutics to Present Data on Its Epilepsy Programs at American Epilepsy Society Annual Meeting (2022)

02 дек 2022 09:00:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights

08 ноя 2022 07:00:02 Источник Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the Ladenburg Thalmann 2022 Healthcare Conference

27 сен 2022 07:00:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

07 сен 2022 07:00:02 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights

09 авг 2022 07:00:02 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Presents Preclinical Data on OV329 at the Epilepsy Foundation Pipeline Conference

06 июн 2022 07:00:02 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights

10 май 2022 07:00:04 Источник Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

08 апр 2022 07:00:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2021 Financial Results

15 мар 2022 07:00:03 Источник Nasdaq GlobeNewswire

Ovid Therapeutics to Participate at the Cowen 42nd Annual Health Care Conference

04 мар 2022 07:00:00 Источник Nasdaq GlobeNewswire

Healx and Ovid Therapeutics to Enter Strategic Partnership

08 фев 2022 07:00:03 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Expands Epilepsy Franchise with Novel KCC2 Activators

03 янв 2022 05:30:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Reports Third Quarter 2021 Business Update, Corporate Highlights and Financial Results

10 ноя 2021 07:30:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Appoints Dr. Kevin Fitzgerald to Board of Directors

07 окт 2021 07:30:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

07 сен 2021 07:00:01 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Highlights

16 авг 2021 07:00:02 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Strengthens Board & Leadership Team to Focus Efforts on Expanding Its Neurosciences Capabilities

08 июл 2021 15:30:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference

07 июл 2021 07:00:01 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Appoints Jeff Rona as Chief Business and Financial Officer

04 июн 2021 07:00:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Appoints Dr. Joy A. Cavagnaro and Dr. Bruce A. Sullenger to its Scientific Advisory Board

26 май 2021 07:00:02 Источник Nasdaq GlobeNewswire